Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Gland Pharma's acquisition of Cenexi in April 2023 has strengthened its European presence, with the region's revenue share rising to 22% in FY26 from 5% in FY23
More than half of the cohort continued therapy beyond 6 months (the median duration was 6 months) with only 4 patients extending therapy beyond 12 months
This is why, for so many patients with PsA and RA, biologics only work partially
Dual- and triple-receptor agonists acting via different receptors and postreceptor pathways seem attractive in view of potentially additive or synergistic effects in the treatment of T2D and obesity
US$ 20.56
US$ 28.10
US$ 24.88
US$ 21.30
US$ 25.22
US$ 29.31
US$ 27.19
US$ 24.52
